Showing results (81-90 of 280) with videos related to
Sort By:
Pageof 28
Klinische Wochenschrift|December 2, 1985
Functional surface structures on human natural killer cellsR E Schmidt, T Hercend, S F Schlossman, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signalingS Hannier, M Tournier, G Bismuth, et al.European Journal of Immunology|October 10, 2001
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathwayN Iouzalen, S Andreae, S Hannier, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Further evidence for a gamma/delta T cell receptor-mediated TCT.1/CD48 recognitionF Mami-Chouaib, P Del Porto, D Delorme, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Characterization of an antigen expressed by human natural killer cellsJ D Griffin, T Hercend, R Beveridge, et al.The Journal of Urology|September 1, 1983
Recovery of renal function after 72 days of anuria caused by ureteral obstructionM Hata, M Tachibana, N Deguchi, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|November 1, 1992
[Analysis of early and late complications and their origins in Kock continent urinary reservoir following technical modification]M Tachibana, N Deguchi, S Jitsukawa, et al.Journal of Applied Physiology|February 1, 1975
A bidirectional respiratory flowmeter using the hot-wire principleI Yoshiya, T Nakajima, I Nagai, et al.Journal of the National Cancer Institute|June 1, 1981
Prevention of spontaneous tumors of aged mice by immunopharmacologic manipulation: study of immune antitumor mechanismsM Bruley-Rosset, T Hercend, J Martinez, et al.European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administrationS El mir, A Casanova, D Betbeder, et al.Pageof 28